Citations

Clear

1011 citation(s) found for "Barry, WT".

An Ultraminiature MEMS Pressure Sensor With High Sensitivity for Measurement of Intramuscular Pressure (IMP) in Patients With Neuromuscular Diseases
Sezen, Serdar , Rajamani, Rajesh , Morrow, Duane A., Kaufman, Kenton R. , Gilbert, Barry K., Kaufman, Kenton R

Mayo Clinic

Journal of Medical Devices | September 3, 2009 | Volume: 3 | Issue: 3 | Pages: No page available

10.1115/1.3192103 Get It

An ultraminiature micropressure sensor to accurately measure intramuscular pressure has been developed. The MEMS sensor is fabricated through surface micromachining and consists of a capacitive array of eight 150 μm diameter sensing membranes connected in parallel. The membranes have been vacuum-sealed via a subsequent deposition and patterning batch microfabrication step. A deep reactive ion etcher (DRIE) based postfabrication self-release has been utilized to fabricate individual devices. Each device has an outline that incorporates specially designed “anchor” structures that are utilized to attach on the muscle tissue during measurements to minimize the effect of muscle contractions on sensor readings. Electrical isolation of the wire bonds and bonding pads has been accomplished by utilizing glob-topping technique. The fabricated sensor performance has been experimentally validated inside a pressure chamber. The current sensors have 0.2 mm Hg pressure resolution in the ±19 mm Hg dynamic range with negligible hysteresis and show a flat frequency response in the 0–5.5 Hz experimental test range.
Response to Letter Regarding Article, “Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy”
Maron, Martin S. , Finley, John, Udelson, James E. , Bos, J. Martijn , Ackerman, Michael J. , Hauser, Thomas H. , Manning, Warren J. , Haas, Tammy S., Lesser, John R. , Maron, Barry J. , Bos, Johan M

Mayo Clinic

Circulation | June 8, 2009 | Volume: 119 | Issue: 22 | Pages: No page available

10.1161/circulationaha.108.843052 Get It

Integrating Health Status and Survival Data: The Palliative Effect of Lung Volume Reduction Surgery
Benzo, Roberto, Farrell, Max H., Chang, Chung-Chou H., Reilly, John J. , Wise, Robert A. , Luketich, James D. , Fishman, Alfred P., Sciurba, Frank C. , Martínez, Fernando J. , Kaplan, Robert M. , Criner, Gerard J. , Make, Barry J. , Wise, Robert

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 29, 2009 | Volume: 180 | Issue: 3 | Pages: 239-246

10.1164/rccm.200809-1383oc | PMID 19483114 Get It

Abstract Rationale In studies that address health-related quality of life (QoL) and survival, subjects who die are usually censored from QoL assessments. This practice tends to inflate the apparent benefits of interventions with a high risk of mortality. Assessing a composite QoL-death outcome is a potential solution to this problem. Objectives To determine the effect of lung volume reduction surgery (LVRS) on a composite endpoint consisting of the occurrence of death or a clinically meaningful decline in QoL defined as an increase of at least eight points in the St. George's Respiratory Questionnaire total score from the National Emphysema Treatment Trial. Methods In patients with chronic obstructive pulmonary disease and emphysema randomized to receive medical treatment (n = 610) or LVRS (n = 608), we analyzed the survival to the composite endpoint, the hazard functions and constructed prediction models of the slope of QoL decline. Measurements and Main Results The time to the composite endpoint was longer in the LVRS group (2 years) than the medical treatment group (1 year) (P < 0.0001). It was even longer in the subsets of patients undergoing LVRS without a high risk for perioperative death and with upper-lobe-predominant emphysema. The hazard for the composite event significantly favored the LVRS group, although it was most significant in patients with predominantly upper-lobe emphysema. The beneficial impact of LVRS on QoL decline was most significant during the 2 years after LVRS. Conclusions LVRS has a significant effect on the composite QoL-survival endpoint tested, indicating its meaningful palliative role, particularly in patients with upper-lobe–predominant emphysema.
Chemical Modification with High Molecular Weight Polyethylene Glycol Reduces Transduction of Hepatocytes and Increases Efficacy of Intravenously Delivered Oncolytic Adenovirus
Doronin, Konstantin, Shashkova, Elena V. , May, Shannon M., Hofherr, Sean, Barry, Michael A. , Barry, Michael A

Mayo Clinic

Human Gene Therapy | May 26, 2009 | Volume: 20 | Issue: 9 | Pages: 975-988

10.1089/hum.2009.028 | PMID 19469693 Get It

Age-Associated Increases in Pulmonary Artery Systolic Pressure in the General Population
Kane, Garvan C. , Enders, Felicity , Rodeheffer, Richard J. , Redfield, Margaret M. , Lam, Carolyn S.P. , Borlaug, Barry A. , Enders, Felicity T

Mayo Clinic

Circulation | May 11, 2009 | Volume: 119 | Issue: 20 | Pages: 2663-2670

10.1161/circulationaha.108.838698 | PMID 19433755 Get It

Background— In contrast to the wealth of data on isolated systolic hypertension involving the systemic circulation in the elderly, much less is known about age-related change in pulmonary artery systolic pressure (PASP) and its prognostic impact in the general population. We sought to define the relationship between PASP and age, to evaluate which factors influence PASP, and to determine whether PASP is independently predictive of mortality in the community. Methods and Results— A random sample of the Olmsted County, Minn, general population (n=2042) underwent echocardiography and spirometry and was followed up for a median of 9 years. PASP was measured from the tricuspid regurgitation velocity. Left ventricular diastolic pressure was estimated with Doppler echocardiography (E/e′ ratio), and arterial stiffening was assessed from the brachial artery pulse pressure. Among 1413 subjects (69%) with measurable PASP (age, 63±11 years; 43% male), median PASP was 26 mm Hg (25th to 75th percentile, 24 to 30 mm Hg) and increased with age ( r =0.31, P <0.001). Independent predictors of PASP were age, pulse pressure, and mitral E/e′ (all P ≤0.003). Increasing PASP was associated with higher mortality (hazard ratio, 2.73 per 10 mm Hg; P <0.001). In subjects without cardiopulmonary disease (any heart failure, coronary artery disease, hypertension, diabetes mellitus, or chronic obstructive lung disease), the age-adjusted hazard ratio was 2.74 per 10 mm Hg ( P =0.016). Conclusions— We provide the first population-based evidence of age-related increase in pulmonary artery pressure, its association with increasing left heart diastolic pressures and systemic vascular stiffening, and its negative impact on survival. Pulmonary artery pressure may serve as a novel cardiovascular risk factor and potential therapeutic target.
Neurotrophic Factor–Expressing Mesenchymal Stem Cells Survive Transplantation into the Contused Spinal Cord Without Differentiating into Neural Cells
Rooney, Gemma E., McMahon, Siobhán S. , Ritter, Thomas , Moran, Cathal J., Madigan, Nicolas N. , Flügel, Alexander , Dockery, Peter , O’Brien, Timothy , Howard, Linda , Windebank, Anthony J. , Barry, Frank , García, Yolanda García

Mayo Clinic

Tissue Engineering Part A | March 31, 2009 | Volume: 15 | Issue: 10 | Pages: 3049-3059

10.1089/ten.tea.2009.0045 | PMID 19335061 Get It

Adenovirus Activates Complement by Distinctly Different Mechanisms In Vitro and In Vivo: Indirect Complement Activation by Virions In Vivo
Xu, Zhili , Hofherr, Sean, Barry, Michael A. , Byrnes, Andrew P. , Tian, Jie , Smith, Jeffrey S. , Barry, Michael A

Mayo Clinic

Journal of Virology | March 26, 2009 | Volume: 83 | Issue: 11 | Pages: 5648-5658

10.1128/jvi.00082-09 | PMID 19321608 Get It

ABSTRACTUnderstanding innate immunity is key to improving the safety of adenovirus (Ad) vectors for systemic gene therapy. Ad has been shown to activate complement in vitro, but activation of complement after Ad injection in vivo has not been directly measured. Using complement protein C3a as a marker of complement activation, we show that types 2 and 5 human Ads cause rapid complement activation after intravenous injection in mice. Unexpectedly, the mechanisms in vivo were different than those in vitro. Antibodies were critical for the activation of complement by Ad in vitro, but antibodies were not required in vivo. The classical pathway was required in vitro, whereas complement activation in vivo involved both classical and nonclassical pathways as well as the reticuloendothelial system. Remarkably, the entry-deficient Ad mutantts1 was completely unable to activate complement in vivo even though it was fully able to activate complement in vitro. This result demonstrates that the complement system senses intravenously injected Ad primarily by detecting the effects of Ad on cells rather than through direct interaction of complement with virions. Encouragingly, shielding Ad with polyethylene glycol was effective at reducing complement activation both in vitro and in vivo. In summary, intravenously injected Ad rapidly activates complement through multiple pathways, but these pathways are different than those identified by in vitro studies. In vitro studies are poorly predictive of in vivo mechanisms because Ad virions activate complement through indirect mechanisms in vivo.
Carotid Repair Using Autologous Adipose-Derived Endothelial Cells
Froehlich, Harald , Gulati, Rajiv , Boilson, Barry A. , Witt, Tyra A. , Harbuzariu, Adriana , Kleppe, Laurel S., Dietz, Allan B. , Simari, Robert D., Lerman, Amir , Dietz, Allan B

Mayo Clinic

Stroke | March 13, 2009 | Volume: 40 | Issue: 5 | Pages: 1886-1891

10.1161/strokeaha.108.539932 | PMID 19286583 Get It

Background and Purpose— Adipose tissue is an abundant source of endothelial cells as well as stem and progenitor cells which can develop an endothelial phenotype. It has been demonstrated that these cells have distinct angiogenic properties in vitro and in vivo. However, whether these cells have the capacity to directly improve large vessel form and function after vascular injury remains unknown. To define whether delivery of adipose-derived endothelial cells (ADECs) would improve healing of injured carotid arteries, a rabbit model of acute arterial injury was used. Methods— Autologous rabbit ADECs were generated using defined culture conditions. To test the ability of ADECs to enhance carotid artery repair, cells were delivered intraarterially after acute balloon injury. Additional delivery studies were performed after functional selection of cells before delivery. Results— After rabbit omental fat harvest and digestion, a proliferative, homogenous, and distinctly endothelial population of ADECs was identified. Direct delivery of autologous ADECs resulted in marked reendothelialization 48 hours after acute vascular injury as compared to saline controls (82.2±26.9% versus 4.2±3.0% P <0.001). Delivery of ADECs that were selected for their ability to take up acetylated LDL significantly improved vasoreactivity and decreased intimal formation after vascular injury. Conclusions— Taken together, these data suggest that ADECs represent an autologous source of proliferative endothelial cells, which demonstrate the capacity to rapidly improve reendothelialization, improve vascular reactivity, and decrease intimal formation in a carotid artery injury model.
Motor and Somatosensory Evoked Potentials
Shine, Timothy, Harrison, Barry, Ruyter, Martin L. De, Daube, Jasper R., Stapelfeldt, Wolf H. , Cherry, Kenneth J., Gloviczki, Péter , Bower, Thomas C., Crook, Julia E. , Heckman, Michael G. , Murray, Michael J. , Gloviczki, Péter

Mayo Clinic

Anesthesiology | March 5, 2009 | Volume: 108 | Issue: 4 | Pages: 580-587

10.1097/aln.0b013e318168d921 | PMID 18362588 Get It

Background Paraplegia is a devastating complication for patients undergoing repair of thoracoabdominal aortic aneurysms. A monitor to detect spinal cord ischemia is necessary if anesthesiologists are to intervene to protect the spinal cord during aortic aneurysm clamping. Methods The medical records of 60 patients who underwent thoracoabdominal aortic aneurysm repair with regional lumbar epidural cooling with evoked potential monitoring were reviewed. The authors analyzed latency and amplitude of motor evoked potentials, somatosensory evoked potentials, and H reflexes before cooling and clamping, after cooling and before clamping, during clamping, and after release of aortic cross clamp. Results Twenty minutes after the aortic cross clamp was placed, motor evoked potentials had 88% sensitivity and 65% specificity in predicting spinal cord ischemia. The negative predictive value of motor evoked potentials at 20 min after aortic cross clamping was 96%. Conclusions Rapid loss of motor evoked potentials or H reflexes after application of the aortic cross clamp identifies a subgroup of patients who are at high risk of developing spinal cord ischemia and in whom aggressive anesthetic and surgical interventions may be justified.
How should hypertrophic cardiomyopathy be classified?
Maron, Barry J. , Seidman, Christine E. , Ackerman, Michael J. , Towbin, Jeffrey A. , Maron, Martin S. , Ommen, Steve R. , Elliott, Perry , Nishimura, Rick A. , Gersh, Bernard J. , Seidman, Christine E

Mayo Clinic

Circulation: Cardiovascular Genetics | February 17, 2009 | Volume: 2 | Issue: 1 | Pages: 81-86

10.1161/circgenetics.108.788703 | PMID 20031569 Get It